Epigenetic marks like DNA methylation and histone modifications quietly decide which genes get switched on or off, shaping the transcriptional programs that define each cell’s identity. Think of them as tiny annotations on your DNA that don’t change the code itself but control how it’s read. These marks respond to diet, stress, and environment, meaning your lifestyle can literally influence gene activity. Because of this flexibility, epigenetic regulation is central to development, disease, and even memory. Understanding how these marks guide transcription helps explain why identical twins can age differently or why some traits skip generations entirely.<\/p>\n

Chromatin Remodeling Complexes and Nucleosome Positioning<\/h3>\n

Epigenetic marks shape transcriptional programs by regulating gene accessibility without altering DNA sequence. DNA methylation, histone modifications, and chromatin remodeling collectively determine which genes are active or silenced in a given cell type. These marks respond to developmental cues and environmental signals, enabling stable yet adaptable gene expression patterns. Epigenetic regulation of transcription<\/strong> is essential for cell differentiation, tissue identity, and disease progression.<\/p>\n

\n
• DNA methylation typically represses transcription when located in promoter regions.<\/li>\n
• Histone acetylation generally promotes gene activation by loosening chromatin.<\/li>\n
• Histone methylation can either activate or repress depending on the specific residue.<\/li>\n<\/ul>\n

  <\/p>\n

  Disruption of these marks can lead to widespread transcriptional dysregulation.<\/em><\/p>\n

  Three-Dimensional Topology and Topologically Associating Domains<\/h3>\n

  Epigenetic marks are the master regulators that shape transcriptional programs without altering DNA sequence. DNA methylation, histone modifications, and chromatin remodeling collectively determine which genes remain active or silent. These marks respond to environmental cues, enabling cells to adapt swiftly. Epigenetic regulation of gene expression<\/strong> governs everything from development to disease resistance. Histone acetylation<\/mark> typically loosens chromatin, promoting transcription, while methylation can either activate or repress depending on context. Understanding these mechanisms unlocks powerful strategies for precision medicine and targeted therapies. Harnessing epigenetic marks is no longer optional\u2014it is essential for decoding cellular identity and controlling gene activity with unprecedented accuracy.<\/p>\n

  From Bench to Bedside: Clinical and Agricultural Implications<\/h2>\n

  Imagine a scientist peering through a microscope at a tiny seedling, never guessing that this humble discovery would one day save a farmer\u2019s harvest and a patient\u2019s life. That journey\u2014from bench to bedside<\/strong>\u2014transforms raw laboratory findings into real-world solutions. In medicine, it means translating molecular insights into therapies; in agriculture, it means turning genetic clues into resilient crops. <\/p>\n

  Every breakthrough lives twice: once as a hypothesis, once as hope.<\/p><\/blockquote>\n

  Yet the path demands rigorous trials, ethical oversight, and cross-sector collaboration. When clinical and agricultural implications align, we don\u2019t just advance translational research<\/strong>\u2014we cultivate a healthier, more food-secure world for generations.<\/p>\n

  Non-Coding Mutations in Mendelian Disorders<\/h3>\n

  Translating discoveries from bench to bedside and field demands rigorous validation, regulatory navigation, and stakeholder collaboration. Clinical and agricultural implications<\/strong> often hinge on reproducibility, dosing, and environmental variables that differ sharply between controlled labs and real-world settings. Researchers must prioritize safety, efficacy, and scalability before adoption. Never assume a promising in vitro result will survive the complexities of human patients or open farmland.<\/em> To bridge this gap effectively, follow these essential steps:<\/p>\n

  \n
  1. Validate biomarkers or crop traits across diverse populations and soil types.<\/li>\n
  2. Engage clinicians, farmers, and regulators early in trial design.<\/li>\n
  3. Implement adaptive monitoring for off-target effects and yield stability.<\/li>\n
  4. Secure ethical and environmental approvals before deployment.<\/li>\n<\/ol>\n

     Cancer Genomes and Dysregulated Enhancer Landscapes<\/h3>\n

     Getting science from the lab to the real world is what translational research impact<\/strong> is all about. In medicine, it means turning discoveries into treatments that actually help patients. In agriculture, it’s about creating crops that survive droughts or resist pests. The goal is simple: make research useful. That journey isn’t always quick, but it’s worth it. Whether it’s a new drug or a tougher tomato, the payoff is real. Scientists, farmers, and doctors all play a part in bridging that gap.<\/p>\n

     Precision Medicine Targeting Regulatory Elements<\/h3>\n

     Translating discoveries from the lab to real-world impact defines bench-to-bedside applications<\/strong>. In medicine, this pipeline accelerates drug development, personalized therapies, and diagnostics that save lives. In agriculture, it yields drought-resistant crops, biofortified foods, and eco-friendly pest controls. This translational science<\/mark> bridges molecular biology and practical solutions, ensuring innovations reach farmers and patients faster. Key benefits include:<\/p>\n

     \n
     • Faster regulatory approvals for novel treatments<\/li>\n
     • Climate-smart crops boosting food security<\/li>\n
     • Precision medicine tailored to individual genetics<\/li>\n<\/ul>\n

       Crop Improvement Through Regulatory Variation<\/h3>\n

       What begins as a single discovery at the laboratory bench often travels a long road before it changes lives. In medicine, translational research<\/strong> transforms molecular insights into therapies that heal patients, while in agriculture, the same journey turns gene discoveries into hardier, higher-yielding crops. Researchers once studied a drought-resistant gene in a tiny plant; today, that knowledge feeds entire communities. From clinical trials to field tests, the path demands collaboration, funding, and patience. Ultimately, bench-to-bedside science proves that a microscope’s quiet breakthrough can ripple outward\u2014nourishing bodies, protecting harvests, and bridging the gap between curiosity and real-world impact.<\/p>\n

       Evolutionary Perspectives on Gene Control Systems<\/h2>\n

       Imagine a microscopic arms race unfolding over eons, where survival hinges not on strength, but on timing. Evolutionary perspectives on gene control systems<\/strong> reveal how ancient organisms gradually built intricate molecular switches to respond to hunger, heat, and hostility. Early life relied on simple repressors, but duplication and mutation birthed enhancers, silencers, and epigenetic marks. Natural selection favored lineages that could fine-tune gene expression without altering DNA itself. Over time, this flexibility allowed complex bodies to evolve, proving that regulatory evolution<\/strong> often drives innovation more than new genes alone. Every heartbeat and thought echoes that silent, ancient struggle for precise control.<\/p>\n

       <\/p>\n

       Conservation and Divergence of Cis-Regulatory Modules<\/h3>\n

       Imagine ancient cells fighting for survival, where random mutations threatened chaos. Over eons, evolutionary gene control systems<\/strong> emerged as nature\u2019s elegant solution. Instead of hardwiring every response, organisms evolved regulatory networks\u2014promoters, enhancers, and repressors\u2014that decide when, where, and how much a gene speaks. This flexibility let creatures adapt to shifting climates and diets without rewriting their entire DNA. Key milestones included:<\/p>\n

       \n
       • Operons in bacteria for swift metabolic switches<\/li>\n
       • Transcription factor families expanding in eukaryotes<\/li>\n
       • Epigenetic marks locking in stable cell identities<\/li>\n<\/ul>\n

         Thus, gene control became evolution\u2019s toolkit for complexity, turning a static genome into a dynamic, story-driven survival machine.<\/p>\n

         Transposable Elements as Raw Material for Novel Enhancers<\/h3>\n

         Evolutionary perspectives on gene control systems<\/strong> reveal how regulatory networks adapt across species. Rather than changes in protein-coding sequences, much evolution arises from mutations in cis-regulatory elements and transcription factor binding sites. These shifts alter when, where, and how strongly genes are expressed, driving morphological and physiological diversity. Comparative genomics shows that conserved regulators often acquire new targets, while duplicated genes diverge in control. Natural selection acts on regulatory variation, favoring plasticity or canalization depending on environmental stability. Consequently, gene regulation is both a source of evolutionary novelty and a constraint, as rewiring can disrupt developmental pathways.<\/p>\n

         \n
         • Q: What evolves most often? A: Regulatory sequences, not just proteins.<\/li>\n
         • Q: Why does it matter? A: It explains biodiversity without new genes.<\/li>\n<\/ul>\n

           Comparative Genomics Across Model Organisms<\/h3>\n

           Evolutionary perspectives reveal that gene control systems<\/strong> are not static blueprints but dynamic architectures shaped by natural selection over billions of years. From prokaryotic operons to eukaryotic enhancer networks, regulatory mechanisms evolve to optimize energy use and environmental response. This adaptive tuning explains why transcription factor binding sites<\/mark> diverge rapidly between species while core promoters remain conserved. Ultimately, studying gene regulation through an evolutionary lens empowers us to predict how organisms adapt to stress, disease, and climate change. Harness this insight to advance synthetic biology and precision medicine with unwavering confidence.<\/p>\n

           Emerging Technologies and Future Directions<\/h2>\n

           The future of communication is being rewritten in real time by rapid advances in artificial intelligence and neural interfaces. Emerging language technologies<\/strong> like real-time translation earbuds and AI co-writers are dissolving barriers between tongues, while generative AI models<\/strong> evolve into personalized tutors and creative partners. Soon, brain-computer interfaces<\/mark> may let thoughts flow directly into text, bypassing keyboards entirely. Quantum computing promises near-instant processing of massive linguistic datasets, enabling context-aware systems that understand nuance, humor, and cultural subtext. As these tools mature, ethical guardrails and digital inclusivity will become critical, ensuring that the next wave of innovation empowers every voice rather than silencing the vulnerable.<\/p>\n

           CRISPR Screens for Functional Regulatory Discovery<\/h3>\n

           Emerging technologies are reshaping the future of intelligent systems at breathtaking speed. From quantum computing and neuromorphic chips to edge AI and autonomous agents, the next decade will reward organizations that embrace AI-driven digital transformation<\/strong> early. Expect breakthroughs in generative models, brain-computer interfaces, and sustainable computing that redefine how we work, communicate, and innovate. Companies that invest today will lead tomorrow’s markets, while laggards risk obsolescence. The future belongs to bold adopters, not cautious observers.<\/p>\n

           Long-Read Sequencing for Complex Structural Variants<\/h3>\n

           Emerging technologies are reshaping the future of intelligent systems at breathtaking speed. From neuromorphic chips that mimic the brain to quantum-assisted machine learning, the next decade promises breakthroughs once confined to science fiction. Emerging AI technologies and future directions<\/strong> will hinge on edge computing, autonomous agents, and human-AI collaboration, enabling real-time decisions in healthcare, mobility, and climate modeling. Yet, this rapid evolution demands responsible governance, transparency, and inclusive design. Staying ahead means embracing continuous learning and agile adaptation. The organizations that thrive will be those treating innovation not as a destination, but as an ongoing, dynamic journey.<\/p>\n

           Spatial Transcriptomics and Tissue-Specific Regulation<\/h3>\n

           Emerging technologies are reshaping how industries innovate and scale. Artificial intelligence and quantum computing<\/strong> stand at the forefront, driving breakthroughs in healthcare, finance, and logistics. Businesses that adopt these tools early will define the next decade of competition.<\/em> Key future directions include:<\/p>\n

           \n
           • Generative AI for autonomous content and code creation<\/li>\n
           • Quantum encryption for ultra-secure communications<\/li>\n
           • Brain-computer interfaces for seamless human-machine interaction<\/li>\n<\/ul>\n

             These advances will lower costs, accelerate discovery, and unlock entirely new markets.<\/p>\n

             Synthetic Biology Tools for Rewiring Control Circuits<\/h3>\n

             Emerging technologies are reshaping the future of computing, communication, and society. Artificial intelligence and quantum computing<\/strong> stand out as transformative forces, enabling faster drug discovery, optimized logistics, and secure encryption. Other promising directions include brain-computer interfaces, autonomous systems, and sustainable energy storage. Key areas driving change include:<\/p>\n

             \n
             • Generative AI and multimodal models<\/li>\n
             • Quantum-safe cryptography<\/li>\n
             • Edge and neuromorphic computing<\/li>\n
             • Extended reality and digital twins<\/li>\n<\/ul>\n

               These advances promise greater efficiency and personalization, yet raise ethical, regulatory, and workforce challenges that will shape adoption over the coming decade.<\/p>\n

               Challenges in Data Interpretation and Reproducibility<\/h2>\n

               Maya stared at the dashboard, where two analysts had drawn opposite conclusions from the same dataset. This is the quiet crisis of data interpretation<\/strong>: without shared protocols, even rigorous work becomes a mirror of assumptions. One team cleans outliers; another keeps them. One reports confidence intervals; another reports p-values. Then comes the harder blow\u2014reproducibility. A promising result evaporates when a new analyst runs the pipeline and gets a different number. Numbers do not lie, but they whisper differently to each listener.<\/em> Building reproducible research<\/strong> means documenting every choice, sharing code, and treating ambiguity as a finding, not a failure.<\/p>\n

               Batch Effects and Normalization in Epigenomic Datasets<\/h3>\n

               Maya spent three weeks chasing a result that vanished the moment a colleague reran her script. Behind that frustrating moment lies a familiar story in modern research: the challenges in data interpretation and reproducibility<\/strong> that quietly undermine trust in findings. Analysts make countless small choices\u2014how to clean outliers, which model to fit, when to stop tuning\u2014and each decision shapes the conclusion. Add fragile pipelines, undocumented code, and shifting software versions, and replication becomes nearly impossible. The consequence is a growing credibility crisis, where even honest results struggle to survive independent scrutiny. Building transparent workflows, sharing raw data, and documenting every step are no longer optional courtesies; they are the foundation of reliable science.<\/p>\n

               Distinguishing Causality from Correlation in Regulatory Networks<\/h3>\n

               Maya spent three weeks recreating a promising result, only to discover the original analysis had quietly dropped outliers. Such challenges in data interpretation and reproducibility<\/strong> haunt modern research: ambiguous metrics, hidden preprocessing steps, and cherry-picked parameters make findings fragile. Without shared code, raw data, or clear documentation, even careful scientists drift into irreproducible territory. The consequences ripple outward\u2014wasted funding, eroded trust, and stalled progress. To fight back, teams must embrace transparency, preregistration, and open notebooks. Only then can a single result become a sturdy brick rather than a sandcastle washed away by the next tide of scrutiny.<\/p>\n

               Ethical Considerations in Editing Regulatory Sequences<\/h3>\n

               Challenges in data interpretation and reproducibility stem from inconsistent methodologies, opaque preprocessing steps, and selective reporting that bias analytical outcomes. To strengthen research integrity, adopt these practices:<\/p>\n

               \n
               • Pre-register hypotheses and analysis plans before data collection.<\/li>\n
               • Document code, parameters, and software versions in shared repositories.<\/li>\n
               • Report negative results and full statistical outputs, not just significant findings.<\/li>\n<\/ul>\n

                 Transparent workflows are the strongest defense against irreproducible science.<\/em> Embracing open data and standardized protocols transforms fragile conclusions into verifiable evidence.<\/p>\n","protected":false},"excerpt":{"rendered":"

                 Regulatory Genomics: Decoding Gene Regulation and Non-Coding DNA Regulatory genomics explores how non-coding DNA sequences control gene expression, shaping when, where, and how genes are turned on or off. By mapping promoters, enhancers, and other regulatory elements, this field reveals the genomic logic behind development, disease, and cellular identity. Understanding these control mechanisms is essential for interpreting genetic variation and advancing precision medicine. Decoding the Non-Coding Genome: Why Regulatory Elements Matter Decoding the non-coding genome reveals that the vast majority of our DNA does not encode proteins but instead controls when, where, and how genes are expressed. Regulatory elements such as enhancers, promoters, and silencers act as molecular switches, and their disruption is increasingly linked to cancer, autoimmune disorders, and developmental diseases. Without understanding these regions, genetic diagnosis remains incomplete and therapies miss critical targets. Ignoring non-coding regulatory elements means ignoring the root cause of countless diseases. Advances in epigenomics and CRISPR screening now make it possible to map these switches at scale, turning once-junk DNA into actionable clinical insight. Regulatory element discovery is therefore not optional\u2014it is the next frontier of precision medicine. Promoters, Enhancers, and Silencers: A Functional Primer The non-coding genome, once dismissed as \u201cjunk DNA,\u201d actually contains critical gene regulatory elements such as promoters, enhancers, and silencers. These sequences do not encode proteins but control when, where, and how much genes are expressed. Decoding them matters because mutations in regulatory regions can disrupt development, immunity, and metabolism, contributing to cancer, diabetes, and rare disorders. Unlike coding mutations, regulatory variants often act subtly across many genes, complicating diagnosis. Understanding these elements improves genome-wide association studies, CRISPR targeting, and personalized medicine, revealing how sequence variation shapes health without altering protein structure. Insulators and Boundary Elements in Chromatin Organization Decoding the non-coding genome reveals that most human DNA does not encode proteins but instead harbors critical gene regulatory elements. These regions, including promoters, enhancers, and silencers, control when, where, and how much a gene is expressed. Their importance is underscored by genome-wide association studies, which link numerous disease-associated variants to non-coding sequences rather than protein-coding genes. How Non-Coding Variants Influence Gene Expression Most of our DNA doesn’t code for proteins, yet it’s far from useless. Decoding the non-coding genome reveals a hidden world of regulatory elements\u2014switches, enhancers, and promoters\u2014that tell genes when, where, and how much to turn on. Mess these up, and you get everything from rare diseases to cancer. So why care? Because understanding these control panels helps explain why two people with the same gene variant can have wildly different health outcomes. It’s not just about what’s written; it’s about who’s reading it and when. Mapping the Regulatory Landscape with High-Throughput Assays Navigating regulatory compliance for high-throughput assays demands a strategic mapping of evolving guidelines from agencies like the FDA and EMA. Begin by aligning assay validation parameters\u2014accuracy, precision, specificity, and robustness\u2014with ICH Q2(R1) and OECD principles. Prioritize fit-for-purpose qualification rather than full validation where exploratory screening is intended. Establish a traceable audit trail and control documentation early, as regulators scrutinize data integrity under 21 CFR Part 11. When scaling to thousands of compounds, automate plate QC and reference standards to prevent drift. Finally, engage regulators through pre-submission meetings to confirm acceptance criteria. This proactive mapping reduces rework and accelerates regulatory submission readiness without compromising scientific rigor. ChIP-Seq and ATAC-Seq for Transcription Factor Binding High-throughput assays are transforming how researchers navigate the complex regulatory landscape of drug development, enabling rapid, cost-effective screenings that align with stringent compliance standards. By automating thousands of tests simultaneously, these platforms accelerate regulatory-grade safety profiling while reducing human error and turnaround times. Data integrity remains paramount, as every result must withstand agency scrutiny. To succeed, teams should: Validate assays against current FDA and EMA guidelines. Integrate real-time analytics for audit-ready documentation. Prioritize reproducibility to avoid costly delays. Embrace high-throughput solutions\u2014they are not optional, but essential for winning approval faster. DNase Hypersensitivity and FAIRE for Open Chromatin Detection In the labyrinth of modern biotech, researchers once chased regulatory clues one experiment at a time. Then came high-throughput assays for regulatory landscape mapping, turning that slow hunt into a panoramic scan. Thousands of parallel tests now reveal enhancers, promoters, and silencers in a single sweep, like lanterns lighting every corridor at once. Scientists watch transcription factor binding shift under stress, drugs, or disease, building maps that guide safer gene therapies. The result? Faster decisions, fewer blind spots, and a clearer path from bench to regulation. Hi-C and 3C Techniques for Chromosomal Interactions High-throughput assays enable systematic mapping of the regulatory landscape by screening thousands of genetic or chemical perturbations in parallel. These platforms combine reporter systems, next-generation sequencing, and automated imaging to identify cis-regulatory elements, transcription factor binding sites, and epigenetic modifications at scale. Key advantages include: Rapid profiling of enhancers and promoters Quantitative dose-response across many conditions Integration with CRISPR screens for functional validation Such approaches accelerate discovery of regulatory variants linked to disease and improve predictive models of gene expression. Single-Cell Approaches to Regulatory Heterogeneity In the shadow of a looming regulatory deadline, a scientist stared at hundreds of unlabeled vials, each a tiny mystery. Traditional testing would take months. Then came the shift: high-throughput assays for regulatory mapping transformed the slog into a swift scan. Like a lighthouse cutting through fog, these automated platforms screened thousands of compounds daily, flagging hazards and pathways in one sweep. Regulatory compliance no longer meant endless paperwork but real-time data streams. The scientist smiled\u2014what once felt like a maze now had a map, drawn not by hand, but by the quiet hum of robotics. Computational Frameworks for Annotating Control Regions Computational frameworks for annotating control regions are transforming how we decode the regulatory genome. These pipelines integrate chromatin accessibility, histone modifications, and transcription factor binding data to pinpoint enhancers, promoters, and silencers with remarkable precision. By leveraging machine learning and sequence-based deep learning models, they automate the identification of cis-regulatory elements across cell types and conditions. This accelerates discoveries in gene regulation and<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"footnotes":""},"categories":[1],"tags":[],"class_list":["post-16967","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/posts\/16967","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/comments?post=16967"}],"version-history":[{"count":1,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/posts\/16967\/revisions"}],"predecessor-version":[{"id":16968,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/posts\/16967\/revisions\/16968"}],"wp:attachment":[{"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/media?parent=16967"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/categories?post=16967"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/dm.bjitgroup.com\/faceaiservice\/index.php\/wp-json\/wp\/v2\/tags?post=16967"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}